KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Payables (2016 - 2026)

Neogenomics filings provide 17 years of Payables readings, the most recent being $25.9 million for Q1 2026.

  • On a quarterly basis, Payables fell 88.08% to $25.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.9 million, a 88.08% decrease, with the full-year FY2025 number at $23.1 million, down 89.62% from a year prior.
  • Payables hit $25.9 million in Q1 2026 for Neogenomics, up from $23.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $222.4 million in Q4 2024 to a low of $13.7 million in Q3 2022.
  • Median Payables over the past 5 years was $22.6 million (2025), compared with a mean of $67.1 million.
  • Biggest five-year swings in Payables: skyrocketed 1189.84% in 2024 and later crashed 89.62% in 2025.
  • Neogenomics' Payables stood at $20.5 million in 2022, then dropped by 0.86% to $20.3 million in 2023, then soared by 993.66% to $222.4 million in 2024, then crashed by 89.62% to $23.1 million in 2025, then rose by 12.16% to $25.9 million in 2026.
  • The last three reported values for Payables were $25.9 million (Q1 2026), $23.1 million (Q4 2025), and $22.6 million (Q3 2025) per Business Quant data.